{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T03:08:02Z","timestamp":1768532882793,"version":"3.49.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s10741-021-10115-8","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T12:05:23Z","timestamp":1620043523000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Angiotensin receptor-neprilysin inhibition in patients with acute decompensated heart failure: an expert consensus position paper"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6340-3996","authenticated-orcid":false,"given":"Argyrios","family":"Ntalianis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Chrysohoou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Giannakoulas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grigorios","family":"Giamouzis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apostolos","family":"Karavidas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aikaterini","family":"Naka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantinos H.","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sotirios","family":"Patsilinakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Parissis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Tziakas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Kanakakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,1]]},"reference":[{"key":"10115_CR1","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(17)32520-5","volume":"391","author":"N Conrad","year":"2018","unstructured":"Conrad N, Judge A, Tran J, Mohseni H, Hedgecott D, Crespillo AP, Allison M, Hemingway H, Cleland JG, McMurray JJV, Rahimi K (2018) Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet 391:572\u2013580","journal-title":"Lancet"},{"key":"10115_CR2","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1002\/ejhf.1531","volume":"21","author":"PM Seferovic","year":"2019","unstructured":"Seferovic PM, Ponikowski P, Anker SD, Bauersachs J, Chioncel O, Cleland JGF, de Boer RA, Drexel H, Ben Gal T, Hill L, Jaarsma T, Jankowska EA, Anker MS, Lainscak M, Lewis BS, McDonagh T, Metra M, Milicic D, Mullens W, Piepoli MF, Rosano G, Ruschitzka F, Volterrani M, Voors AA, Filippatos G, Coats AJS (2019) Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of The Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 21:1169\u20131186","journal-title":"Eur J Heart Fail"},{"key":"10115_CR3","doi-asserted-by":"publisher","DOI":"10.1177\/2048872614527012","author":"G Filippatos","year":"2014","unstructured":"Filippatos G, Farmakis D, Bistola V, Karavidas A, Mebazaa A, Maggioni AP, Parissis J (2014) Temporal trends in epidemiology, clinical presentation and management of acute heart failure: results from the Greek cohorts of the Acute Heart Failure Global Registry of Standard Treatment and the European Society of Cardiology Heart Failure pilot survey. Eur Heart J Acute Cardiovasc Care. https:\/\/doi.org\/10.1177\/2048872614527012","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10115_CR4","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1093\/eurjhf\/hft050","volume":"15","author":"AP Maggioni","year":"2013","unstructured":"Maggioni AP, Dahlstr\u00f6m U, Filippatos G, Chioncel O, Crespo Leiro M, Drozdz J, Fruhwald F, Gullestad L, Logeart D, Fabbri G, Urso R, Metra M, Parissis J, Persson H, Ponikowski P, Rauchhaus M, Voors AA, Nielsen OW, Zannad F, Tavazzi L (2013) EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot). Heart Failure Association of the European Society of Cardiology (HFA). Eur J Heart Fail 15:808\u2013817","journal-title":"Eur J Heart Fail"},{"key":"10115_CR5","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1016\/j.jacc.2019.08.001","volume":"74","author":"SM Hollenberg","year":"2019","unstructured":"Hollenberg SM, Stevenson LW, Ahmad T, Amin VJ, Bozkurt B, Butler J, Davies L, Drazner MH, Kirkpatrick JN, Peterson PN, Reed BN, Roy CL, Storrow AB (2019) 2019 ACC Expert Consensus Decision Pathway on risk assessment, management, and clinical trajectory of patients hospitalized with heart failure. J Am Coll Cardiol 74:1966\u20132011","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10115_CR6","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.amjmed.2016.05.008","volume":"129","author":"K Sanam","year":"2016","unstructured":"Sanam K, Bhatia V, Bajaj NS, Gaba S, Morgan CJ, Fonarow GC, Butler J, Deedwania P, Prabhu SD, Wu WC, White M, Love TE, Aronow WS, Fletcher RD, Allman RM, Ahmed A (2016) Renin-angiotensin system inhibition and lower 30-day all-cause readmission in Medicare Beneficiaries with heart failure. Am J Med 129(10):1067\u20131073","journal-title":"Am J Med"},{"key":"10115_CR7","doi-asserted-by":"publisher","first-page":"82e1","DOI":"10.1016\/j.ahj.2006.10.008","volume":"153","author":"GC Fonarow","year":"2007","unstructured":"Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O\u2019Connor CM, Sun JL, Yancy C, Young JB (2007) Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J 153:82e1-e11","journal-title":"Am Heart J"},{"key":"10115_CR8","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1093\/eurheartj\/ehp323","volume":"30","author":"G Jondeau","year":"2009","unstructured":"Jondeau G, Neuder Y, Eicher JC, Jourdain P, Fauveau E, Galinier M, Jegou A, Bauer F, Trochu JN, Bouzamondo A, Tanguy ML, Lechat P (2009) B-CONVINCED: beta-blocker CONtinuation Vs. interruption in patients with Congestive heart failure hospitalizED for a decompensation episode. Eur Heart J 30:2186\u20132192","journal-title":"Eur Heart J"},{"key":"10115_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s00392-017-1161-7","volume":"107","author":"V Bistola","year":"2018","unstructured":"Bistola V, Simitsis P, Farmakis D, Ikonomidis I, Bakosis G, Triposkiadis F, Hatziagelaki E, Lekakis J, Mebazaa A, Parissis J (2018) Association of mineralocorticoid receptor antagonist use and in-hospital outcomes in patients with acute heart failure. Clin Res Cardiol 107:76\u201386","journal-title":"Clin Res Cardiol"},{"issue":"27","key":"10115_CR10","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Group ESCSD (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37(27):2129\u20132200","journal-title":"Eur Heart J"},{"issue":"6","key":"10115_CR11","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"CW Yancy","year":"2017","unstructured":"Yancy CW, Jessup M, Bozkurt B et al (2017) 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation 136(6):e137\u2013e161","journal-title":"Circulation"},{"issue":"23","key":"10115_CR12","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1001\/jama.2019.18598","volume":"322","author":"N Kozhuharov","year":"2019","unstructured":"Kozhuharov N, Goudev A, Flores D, Maeder MT, Walter J, Shrestha S, Gualandro DM, de Oliveira MT Jr, Sabti Z, M\u00fcller B, Noveanu M, Socrates T, Ziller R, Bay\u00e9s-Gen\u00eds A, Sionis A, Simon P, Michou E, Gujer S, Gori T, Wenzel P, Pfister O, Conen D, Kapos I, Kobza R, Rickli H, Breidthardt T, M\u00fcnzel T, Erne P, Mueller C, GALACTIC Investigators, Mueller C, Erne P, M\u00fcller B, Rickli H, Maeder M, de Oliveira MT Jr, Bay\u00e9s-Gen\u00eds A, Sionis A, Goudev A, Dimov B, Hartwiger S, Arenja N, Glatz B, Herr N, Isenrich R, Mosimann T, Twerenbold R, Boeddinghaus J, Nestelberger T, Puelacher C, Freese M, V\u00f6gele J, Meissner K, Martin J, Strebel I, Wussler D, Schumacher C, Osswald S, Vogt F, Hilti J, Barata S, Schneider D, Schwarz J, Fitze B, Hartwiger S, Arenja N, Glatz B, Herr N, Isenrich R, Mosimann T, Rentsch K, Bossa A, Jallad S, Soeiro A, Georgiev D, Jansen T, Gebel G, Bossard M, Christ M (2019) Effect of a Strategy of Comprehensive Vasodilation vs Usual Care on Mortality and Heart Failure Rehospitalization Among Patients With Acute Heart Failure: The GALACTIC Randomized Clinical Trial. JAMA 322(23):2292\u20132302","journal-title":"JAMA"},{"issue":"4","key":"10115_CR13","doi-asserted-by":"publisher","first-page":"e006731","DOI":"10.1161\/CIRCHEARTFAILURE.119.006731","volume":"13","author":"H Rosenblum","year":"2020","unstructured":"Rosenblum H, Kapur N, Abraham W, Udelson J, Itkin M, Uriel N, Voors A, Burkhoff D (2020) Conceptual Considerations for Device-Based Therapy in Acute Decompensated Heart Failure: DRI 2 P 2 S. Circ Heart Fail 13(4):e006731. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.119.006731 (Epub 2020 Apr 16)","journal-title":"Circ Heart Fail"},{"issue":"6","key":"10115_CR14","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJMoa1812851","volume":"380","author":"EJ Velazquez","year":"2019","unstructured":"Velazquez EJ, Morrow DA, DeVore AD, Duffy C, Ambrosy A, McCague K, Rocha R, Braunwald E, Investigators PIONEER-HF (2019) Angiotensin-neprilysin inhibition in acute decompensated heart failure. N Engl J Med 380(6):539\u2013548","journal-title":"N Engl J Med"},{"issue":"1","key":"10115_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jchf.2018.06.011","volume":"7","author":"A Bhagat","year":"2019","unstructured":"Bhagat A, Greene S, Vaduganathan M, Fonarow G, Butler J (2019) Initiation, Continuation, Switching, and Withdrawal of Heart Failure Medical Therapies During Hospitalization. JACC Heart Fail 7(1):1\u201312. https:\/\/doi.org\/10.1016\/j.jchf.2018.06.011","journal-title":"JACC Heart Fail"},{"issue":"14","key":"10115_CR16","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1161\/CIRCULATIONAHA.115.014281","volume":"132","author":"L Allen","year":"2015","unstructured":"Allen L, Fonarow G, Liang L, Schulte P, Masoudi F, Rumsfeld J, Ho M, Eapen Z, Hernandez A, Heidenreich P, Bhatt D, Peterson E, Krumholz H, on behalf of the American Heart Association\u2019s Get With The Guidelines Heart Failure (GWTG-HF) Investigators (2015) Medication Initiation Burden Required to Comply with Heart Failure Guideline Recommendations and Hospital Quality Measures. Circulation 132(14):1347\u20131353","journal-title":"Circulation"},{"key":"10115_CR17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ijcard.2015.08.030","volume":"201","author":"D Farmakis","year":"2015","unstructured":"Farmakis D, Parissis J, Karavidas A, Karvounis C, Triposkiadis F, Filippatos G, Lekakis J (2015) In-hospital management of acute heart failure: Practical recommendations and future perspectives. Int J Cardiol 201:231\u2013236","journal-title":"Int J Cardiol"},{"issue":"4","key":"10115_CR18","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1002\/ehf2.12701","volume":"7","author":"A Arvanitaki","year":"2020","unstructured":"Arvanitaki A, Michou E, Kalogeropoulos A, Karvounis H, Giannakoulas G (2020) Mildly symptomatic heart failure with reduced ejection fraction: diagnostic and therapeutic considerations. ESC Heart Fail 7(4):1477\u20131487","journal-title":"ESC Heart Fail"},{"issue":"11","key":"10115_CR19","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJ McMurray","year":"2014","unstructured":"McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, Investigators Committees PH (2014) Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371(11):993\u20131004","journal-title":"N Engl J Med"},{"key":"10115_CR20","doi-asserted-by":"crossref","unstructured":"Desai AS, Solomon SD, Shah AM, Claggett B, Fang J, Izzo J, McCague K, Abbas C, Rocha R, Mitchell G (2019) Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial [published online ahead of print, 2019 Sep 2]. JAMA 322(11):1\u201310","DOI":"10.1001\/jama.2019.12843"},{"key":"10115_CR21","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/ejhf.799","volume":"19","author":"E D\u2019Elia","year":"2017","unstructured":"D\u2019Elia E, Iacovoni A, Vaduganathan M, Lorini FL, Perlini S, Senni M (2017) Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides. Eur J Heart Failure 19:710\u2013717","journal-title":"Eur J Heart Failure"},{"issue":"7","key":"10115_CR22","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jacc.2018.11.042","volume":"73","author":"MR Zile","year":"2019","unstructured":"Zile MR, O\u2019Meara E, Claggett B, Prescott M, Solomon S, Swedberg K, Packer M, McMurray J, Shi V, Lefkowitz M, Rouleay J (2019) Effects of sacubitril\/valsartan on biomarkers of extracellular matrix regulation in patients with HFrEF. J Am Coll Cardiol 73(7):795\u2013806","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10115_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jama.2019.12821","volume":"322","author":"JL Januzzi Jr","year":"2019","unstructured":"Januzzi JL Jr, Prescott MF, Butler J, Felker GM, Maisel AS, McCague K, Camacho A, Pi\u00f1a IL, Rocha RA, Shah AM, Williamson KM, Solomon SD, Investigators PROVE-HF (2019) Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction. JAMA 322(11):1\u201311. https:\/\/doi.org\/10.1001\/jama.2019.12821","journal-title":"JAMA"},{"issue":"6","key":"10115_CR24","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jchf.2018.02.004","volume":"6","author":"K Damman","year":"2018","unstructured":"Damman K, Gori M, Claggett B, Jhund PS, Senni M, Lefkowitz MP, Prescott MF, Shi VC, Rouleau JL, Swedberg K, Zile MR, Packer M, Desai AS, Solomon SD, McMurray JJV (2018) Renal effects and associated outcomes during angiotensin-neprilysin inhibition in heart failure. JACC Heart Fail 6(6):489\u2013498","journal-title":"JACC Heart Fail"},{"issue":"5","key":"10115_CR25","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S2213-8587(17)30087-6","volume":"5","author":"JP Seferovic","year":"2017","unstructured":"Seferovic JP, Claggett B, Seidelmann SB, Seely EW, Packer M, Zile MR, Rouleau JL, Swedberg K, Lefkowitz M, Shi VC, Desai AS, McMurray JJV, Solomon SD (2017) Effect of sacubitril\/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial. Lancet Diabetes Endocrinol 5(5):333\u2013340","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10115_CR26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1001\/jamacardio.2016.4733","volume":"2","author":"AS Desai","year":"2017","unstructured":"Desai AS, Vardeny O, Claggett B, McMurray JJ, Packer M, Swedberg K, Rouleau JL, Zile MR, Lefkowitz M, Shi V, Solomon SD (2017) Reduced risk of hyperkalemia during treatment of heart failure with mineralocorticoid receptor antagonists by use of sacubitril\/valsartan compared with enalapril: a secondary analysis of the PARADIGM-HF Trial. JAMA Cardiol 2(1):79\u201385","journal-title":"JAMA Cardiol"},{"issue":"6","key":"10115_CR27","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.jacc.2020.11.022","volume":"77","author":"TM Maddox","year":"2021","unstructured":"Maddox TM, Januzzi JL Jr, Allen LA, Breathett K, Butler J, Davis LL, Fonarow GC, Ibrahim NE, Lindenfeld J, Masoudi FA, Motiwala SR, Oliveros E, Patterson JH, Walsh MN, Wasserman A, Yancy CW, Youmans QR (2021) 2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol 77(6):772\u2013810","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10115_CR28","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.jchf.2020.05.005","volume":"8","author":"DL Mann","year":"2020","unstructured":"Mann DL, Greene SJ, Givertz MM, Vader JM, Starling RC, Ambrosy AP, Shah P, McNulty SE, Mahr C, Gupta D, Redfield MM, Lala A, Lewis GD, Mohammed SF, Gilotra NA, DeVore A, Gorodeski EZ, Desvigne-Nickens P, Hernandez AF, Braunwald E (2020) Sacubitril\/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction: Rationale and Design of the LIFE Trial. JACC Heart Fail 8(10):789\u2013799","journal-title":"JACC Heart Fail"},{"issue":"8","key":"10115_CR29","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/ejhf.1498","volume":"21","author":"R Wachter","year":"2019","unstructured":"Wachter R, Senni M, Belohlavek J, Straburzynska-Migaj E, Witte KK, Kobalava Z, Fonseca C, Goncalvesova E, Cavusoglu Y, Fernandez A, Chaaban S, B\u00f8hmer E, Pouleur AC, Mueller C, Tribouilloy C, Lonn E, A L Buraiki J, Gniot J, Mozheiko M, Lelonek M, No\u00e8 A, Schwende H, Bao W, Butylin D, Pascual-Figal D; TRANSITION Investigators. (2019) Initiation of sacubitril\/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study. Eur J Heart Fail 21(8):998\u20131007","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10115_CR30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/ejhf.1670","volume":"22","author":"M Senni","year":"2020","unstructured":"Senni M, Wachter R, Witte K, Straburzynska-Migaj E, Belohlavek J, C, Mueller C, Lonn E, Chakrabarti A, Bao W, Noe A, Schwende H, Butylin D, Pascual-Figal D, TRANSITION Investigators. (2020) Initiation of sacubitril\/valsartan shortly after hospitalisation for acutely decompensated heart failure in patients with newly diagnosed (de novo) heart failure: a subgroup analysis of the TRANSITION study. Eur J Heart Fail 22(2):303\u2013312","journal-title":"Eur J Heart Fail"},{"key":"10115_CR31","unstructured":"Pascual-Figal D, Wachter R, Senni M, Bao W, Noe A, Schwende H, Butylin D, Prescott M (2020) NT-proBNP Response to Sacubitril\/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study. JACC Heart Fail S2213\u20131779(20)30336-X"},{"issue":"8","key":"10115_CR32","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1002\/ejhf.1540","volume":"21","author":"AP Ambrosy","year":"2019","unstructured":"Ambrosy AP, DeVore AD, Velazquez EJ (2019) In-hospital initiation of sacubitril\/valsartan in acute decompensated heart failure: being in the right place at the right time. Eur J Heart Fail 21(8):1008\u20131011","journal-title":"Eur J Heart Fail"},{"issue":"40","key":"10115_CR33","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1093\/eurheartj\/ehz240","volume":"40","author":"DA Morrow","year":"2019","unstructured":"Morrow DA, Velazquez EJ, DeVore AD, Prescott M, Duffy C, Gurmu Y, McCague K, Rocha R, Braunwald E (2019) Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial. Eur Heart J 40(40):3345\u20133352","journal-title":"Eur Heart J"},{"issue":"19","key":"10115_CR34","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1161\/CIRCULATIONAHA.118.039331","volume":"139","author":"DA Morrow","year":"2019","unstructured":"Morrow DA, Velazquez EJ, DeVore AD, Desai AS, Duffy CI, Ambrosy AP, Gurmu Y, McCague K, Rocha R, Braunwald E (2019) Clinical Outcomes in Patients With Acute Decompensated Heart Failure Randomly Assigned to Sacubitril\/Valsartan or Enalapril in the PIONEER-HF Trial. Circulation 139(19):2285\u20132288","journal-title":"Circulation"},{"key":"10115_CR35","doi-asserted-by":"crossref","unstructured":"Berg DD, Braunwald E, DeVore AD, Lala A, Pinney SP, Duffy CI, Gurmu Y, Velazquez EJ, Morrow DA (2020) Efficacy and Safety of Sacubitril\/Valsartan by Dose Level Achieved in the PIONEER-HF Trial. JACC Heart Fail S2213\u20131779(20)30384-X","DOI":"10.1016\/j.jchf.2020.06.008"},{"issue":"9","key":"10115_CR36","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.jacc.2020.06.073","volume":"76","author":"AP Ambrosy","year":"2020","unstructured":"Ambrosy AP, Braunwald E, Morrow DA, De Vore A, McCague K, Meng X, Duffy C, Rocha R, Velazquez E (2020) Angiotensin receptor-neprilysin inhibition based on history of heart failure and use of renin-angiotensin system antagonists. J Am Coll Cardiol 76(9):1034\u20131048","journal-title":"J Am Coll Cardiol"},{"key":"10115_CR37","doi-asserted-by":"crossref","unstructured":"DeVore AD, Braunwald E, Morrow DA, Duffy C, Ambrosy A, Chakraborty H, McCague K, Rocha R, Velazquez E (2019) Initiation of Angiotensin-Neprilysin Inhibition After Acute Decompensated Heart Failure: Secondary Analysis of the Open-label Extension of the PIONEER-HF Trial [published online ahead of print, Dec 11]. JAMA Cardiol 5(2):202\u2013207","DOI":"10.1001\/jamacardio.2019.4665"},{"key":"10115_CR38","doi-asserted-by":"crossref","unstructured":"Gaziano TA, Fonarow GC, Velazquez EJ, Morrow DA, Braunwald E, Solomon SD (2020) Cost-effectiveness of Sacubitril-Valsartan in Hospitalized Patients Who Have Heart Failure With Reduced Ejection Fraction. JAMA Cardiol 5(11):1236\u20131244","DOI":"10.1001\/jamacardio.2020.2822"},{"key":"10115_CR39","unstructured":"Greene SJ, Triana TS, Ionescu-Ittu R, Burne R, Guerin A, Borentain M, Kessler P, Tugsu A, DeSouza M, Felker M, Chen L. (2020) In-Hospital Therapy for Heart Failure With Reduced Ejection Fraction in the United States [published online ahead of print, Aug 12]. JACC Heart Fail S2213\u20131779(20)30383\u20138"},{"issue":"3","key":"10115_CR40","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1001\/jamacardio.2019.0104","volume":"4","author":"P Srivastava","year":"2019","unstructured":"Srivastava P, Fonarow G (2019) In-Hospital Initiation of Angiotensin Receptor-Neprilysin Inhibitors-The Time Is Now. JAMA Cardiol 4(3):195\u2013196. https:\/\/doi.org\/10.1001\/jamacardio.2019.0104","journal-title":"JAMA Cardiol"},{"issue":"4","key":"10115_CR41","doi-asserted-by":"publisher","first-page":"e006645","DOI":"10.1161\/CIRCHEARTFAILURE.119.006645","volume":"13","author":"M Fudim","year":"2020","unstructured":"Fudim M, Sayeed S, Xu H, Matsouaka RA, Heidenreich PA, Velazquez EJ, Yancy CW, Fonarow GC, Hernandez AF, DeVore AD (2020) Representativeness of the PIONEER-HF Clinical Trial Population in Patients Hospitalized With Heart Failure and Reduced Ejection Fraction. Circ Heart Fail 13(4):e006645","journal-title":"Circ Heart Fail"},{"issue":"11","key":"10115_CR42","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1002\/ejhf.1492","volume":"21","author":"O Chioncel","year":"2019","unstructured":"Chioncel O, Mebazaa A, Maggioni AP, Harjola VP, Rosano G, Laroche C, Piepoli M, Crespo-Leiro M, Lainscak M, Ponikowski P, Fillipatos G, Ruschitzka F, Seferovic P, Coats A, Lund L (2019) Acute heart failure congestion and perfusion status - impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry. Eur J Heart Fail 21(11):1338\u20131352. https:\/\/doi.org\/10.1002\/ejhf.1492","journal-title":"Eur J Heart Fail"},{"key":"10115_CR43","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ijcard.2015.06.181","volume":"199","author":"CK Antoniou","year":"2015","unstructured":"Antoniou CK, Chrysohoou C, Lerakis S, Manolakou P, Pitsavos C, Tsioufis K, Stefanadis C, Tousoulis D (2015) Effects of ventriculoarterial coupling changes on renal function, echocardiographic indices and energy efficiency in patients with acute decompensated systolic heart failure under furosemide and dopamine treatment: a comparison of three therapeutic protocols. Int J Cardiol 199:44\u201349","journal-title":"Int J Cardiol"},{"issue":"1","key":"10115_CR44","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ijcard.2013.12.276","volume":"172","author":"FK Triposkiadis","year":"2014","unstructured":"Triposkiadis FK, Butler J, Karayannis G, Starling R, Fillipatos G, Wolski K, Parissis J, Parisis C, Rovithis D, Koutrakis K, Skoularigis J, Antoniou CK, Chrysohoou C, Pitsavos C, Stefanadis C, Nastas J, Tsaknakis T, Mantziari L, Giannakoulas G, Karvounis H, Kalogeropoulos A, Giamouzis G (2014) Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial. Int J Cardiol 172(1):115\u2013121","journal-title":"Int J Cardiol"},{"issue":"11","key":"10115_CR45","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/ejhf.1502","volume":"21","author":"P Javaloyes","year":"2019","unstructured":"Javaloyes P, Mir\u00f3 \u00d2, Gil V, Martin-Sanchez FJ, Jacob J, Herrero P, Takagi K, Alquezar-Arbe A, Lopez Diez MP, Martin E, Bibiano C, Escoda R, Gil C, Fuentes M, Llopis Garcia G, Alvarez Perez JM, Jerez A, Tost J, Llauger L, Romero R, Garido JM, Rodriguez-Adrada E, Sanchez C, Rossello X, Parissis J, Mebazza A, Chioncel O, Llorens P (2019) Clinical phenotypes of acute heart failure based on signs and symptoms of perfusion and congestion at emergency department presentation and their relationship with patient management and outcomes. Eur J Heart Fail 21(11):1353\u20131365","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10115_CR46","doi-asserted-by":"publisher","first-page":"308","DOI":"10.6061\/clinics\/2014(05)02","volume":"69","author":"ME Ochiai","year":"2014","unstructured":"Ochiai ME, Brancalh\u00e3o EC, Puig RS, Vieira KR, Cardoso JN, Oliveira MT Jr, Barretto AC (2014) Short-term add-on therapy with angiotensin receptor blocker for end-stage inotrope-dependent heart failure patients: B-type natriuretic peptide reduction in a randomized clinical trial. Clinics (Sao Paulo) 69(5):308\u2013313","journal-title":"Clinics (Sao Paulo)"},{"issue":"2","key":"10115_CR47","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/ejhf.1369","volume":"21","author":"W Mullens","year":"2019","unstructured":"Mullens W, Damman K, Harjola VP, Mebazaa A, Brunner-La Rocca HP, Martens P, Jeffrey Testani J, Tang W, Orso F, Rossignol P, Metra M, Filippatos G, Seferovic P, Ruschitzka F, Coats A (2019) The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 21(2):137\u2013155. https:\/\/doi.org\/10.1002\/ejhf.1369 (Epub 2019 Jan 1)","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"10115_CR48","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/ehjci\/jex067","volume":"18","author":"P Lancellotti","year":"2017","unstructured":"Lancellotti P, Galderisi M, Edvardsen T, Donal E, Goliasch G, Cardim N, Magne J, Laginha S, Hagendorff A, Haland TF, Aaberge L, Martinez C, Rapacciuolo A, Santoro C, Ilardi F, Postolache A, Dulgheru R, Mateescu AD, Beladan CC, Deleanu D, Marchetta S, Auffret V, Schwammenthal E, Habib G, Popescu BA (2017) Echo Doppler estimation of left ventricular filling pressure: results of the multicentre EACVI Euro-Filling study. Eur Heart J Cardiovasc Imaging 18(9):961\u2013968","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"7","key":"10115_CR49","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jchf.2020.03.009","volume":"8","author":"W McCallum","year":"2020","unstructured":"McCallum W, Tighiouart H, Testani J, Griffin M, Konstam M, Udelson J, Sarnak M (2020) Acute kidney function declines in the context of decongestion in acute decompensated heart failure. JACC Heart Fail 8(7):537\u2013547","journal-title":"JACC Heart Fail"},{"key":"10115_CR50","doi-asserted-by":"crossref","unstructured":"Guarracino F, Zima E, Pollesello P, Masip J (2020) Short term treatments for acute cardiac care: inotropes and inodilators. Eur Heart J Suppl 22(Suppl D):D3-D11","DOI":"10.1093\/eurheartj\/suaa090"},{"issue":"10","key":"10115_CR51","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.jacc.2019.12.059","volume":"75","author":"GM Felker","year":"2020","unstructured":"Felker GM, Ellison DH, Mullens W, Cox ZL, Testani JM (2020) Diuretic Therapy for Patients With Heart Failure: JACC State-of-the-Art Review. J Am Coll Cardiol 75(10):1178\u20131195","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10115_CR52","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1161\/01.CIR.0000078348.44634.BA","volume":"108","author":"LW Stevenson","year":"2003","unstructured":"Stevenson LW (2003) Clinical Use of Inotropic Therapy for Heart Failure: Looking Backward or Forward? Part I: Inotropic Infusions During Hospitalization. Circulation 108(3):367\u2013372","journal-title":"Circulation"},{"issue":"9","key":"10115_CR53","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.ejheart.2008.07.014","volume":"10","author":"A Maisel","year":"2008","unstructured":"Maisel A, Mueller C, Adams K Jr, Anker SD, Aspromonte N, Cleland JG, Cohen-Solal A, Dahlstrom U, DeMaria A, Di Somma S, Filippatos GS, Fonarow GC, Jourdain P, Komajda M, Liu PP, McDonagh T, McDonald K, Mebazaa A, Nieminen MS, Peacock WF, Tubaro M, Valle R, Vanderhyden M, Yancy CW, Zannad F, Braunwald E (2008) State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail 10(9):824\u2013839","journal-title":"Eur J Heart Fail"},{"issue":"9916","key":"10115_CR54","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1016\/S0140-6736(14)61373-8","volume":"384","author":"D Kotecha","year":"2014","unstructured":"Kotecha D, Holmes J, Krum H, Altman DG, Manzano L, Cleland JG, Lip GY, Coats AJ, Andersson B, Kirchhof P, von Lueder TG, Wedel H, Rosano G, Shibata MC, Rigby A, Flather MD (2014) Beta-Blockers in Heart Failure Collaborative G. Efficacy of beta blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis. Lancet 384(9961):2235\u20132243","journal-title":"Lancet"},{"key":"10115_CR55","doi-asserted-by":"publisher","unstructured":"Eid PS, Ibrahim DA, Zayan AH, Abdelrahman MM, Shehata MAA, Kandil H, Abouibrahim MA, Duy LM, Shinkar A, Elfaituri MK, Minh LHN, Fahmy MM, Tam DNH, Vuong NL, Shah J, Do VBD, Hirayama K, Huy NT (2020) Comparative effects of furosemide and other diuretics in the treatment of heart failure: a systematic review and combined meta-analysis of randomized controlled trials [published online ahead of print, Aug 11]. Heart Fail Rev https:\/\/doi.org\/10.1007\/s10741-020-10003-7","DOI":"10.1007\/s10741-020-10003-7"},{"issue":"15","key":"10115_CR56","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1093\/eurheartj\/ehw570","volume":"38","author":"M B\u00f6hm","year":"2017","unstructured":"B\u00f6hm M, Young R, Jhund PS, Solomon S, Gong J, Lefkowitz M, Rizkala A, Rouleau J, Shi V, Swedberg K, Zile M, Packer M, McMurray J (2017) Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril\/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF. Eur Heart J 38(15):1132\u20131143. https:\/\/doi.org\/10.1093\/eurheartj\/ehw570","journal-title":"Eur Heart J"},{"key":"10115_CR57","doi-asserted-by":"publisher","unstructured":"McAlister F, Youngson E, Kaul P, Ezekowitz J (2016) Early Follow-Up After a Heart Failure Exacerbation. The Importance of Continuity. Circ Heart Fail 9(9):e003194.\u00a0https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.116.003194","DOI":"10.1161\/CIRCHEARTFAILURE.116.003194"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-021-10115-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-021-10115-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-021-10115-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T02:48:48Z","timestamp":1744166928000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-021-10115-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,1]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10115"],"URL":"https:\/\/doi.org\/10.1007\/s10741-021-10115-8","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,1]]},"assertion":[{"value":"20 April 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors state that there is no conflict of interest regarding this work, although in the past, Dr Christina Chrysohoou, Dr Argyrios Ntalianis, Dr Katerina Naka, and Dr Gregory Giamouzis have received honoraria for lectures from Novartis. Additionally, John Parissis has received honoraria for lectures from Servier, Pfizer, Novartis, Orion Pharma, and Astra Zeneca","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}